- Home
- NEOV vs STXS Comparison
NEOV vs STXS Comparison
Compare NEOV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- STXS
- Stock Information
- Founded
- NEOV 2018
- STXS 1990
- Country
- NEOV United States
- STXS United States
- Employees
- NEOV N/A
- STXS N/A
- Industry
- NEOV Industrial Machinery/Components
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NEOV Miscellaneous
- STXS Health Care
- Exchange
- NEOV Nasdaq
- STXS Nasdaq
- Market Cap
- NEOV 181.8M
- STXS 189.8M
- IPO Year
- NEOV N/A
- STXS 2004
- Fundamental
- Price
- NEOV $4.10
- STXS $2.08
- Analyst Decision
- NEOV Strong Buy
- STXS Strong Buy
- Analyst Count
- NEOV 1
- STXS 2
- Target Price
- NEOV $7.50
- STXS $4.50
- AVG Volume (30 Days)
- NEOV 251.7K
- STXS 422.5K
- Earning Date
- NEOV 02-07-2025
- STXS 03-03-2025
- Dividend Yield
- NEOV N/A
- STXS N/A
- EPS Growth
- NEOV N/A
- STXS N/A
- EPS
- NEOV N/A
- STXS N/A
- Revenue
- NEOV $2,471,178.00
- STXS $25,143,000.00
- Revenue This Year
- NEOV $85.10
- STXS $1.16
- Revenue Next Year
- NEOV $281.25
- STXS $55.65
- P/E Ratio
- NEOV N/A
- STXS N/A
- Revenue Growth
- NEOV N/A
- STXS N/A
- 52 Week Low
- NEOV $0.63
- STXS $1.66
- 52 Week High
- NEOV $6.11
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- NEOV 39.13
- STXS 42.68
- Support Level
- NEOV $4.24
- STXS $2.21
- Resistance Level
- NEOV $4.91
- STXS $2.72
- Average True Range (ATR)
- NEOV 0.48
- STXS 0.16
- MACD
- NEOV -0.11
- STXS -0.04
- Stochastic Oscillator
- NEOV 3.87
- STXS 7.54
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.